JP2018104461A5 - - Google Patents

Download PDF

Info

Publication number
JP2018104461A5
JP2018104461A5 JP2018038513A JP2018038513A JP2018104461A5 JP 2018104461 A5 JP2018104461 A5 JP 2018104461A5 JP 2018038513 A JP2018038513 A JP 2018038513A JP 2018038513 A JP2018038513 A JP 2018038513A JP 2018104461 A5 JP2018104461 A5 JP 2018104461A5
Authority
JP
Japan
Prior art keywords
seq
collagen
therapeutic agent
use according
binding polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018038513A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018104461A (ja
JP6697019B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018104461A publication Critical patent/JP2018104461A/ja
Publication of JP2018104461A5 publication Critical patent/JP2018104461A5/ja
Application granted granted Critical
Publication of JP6697019B2 publication Critical patent/JP6697019B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018038513A 2011-12-14 2018-03-05 コラーゲン結合タンパク質による治療剤の送達 Active JP6697019B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161570620P 2011-12-14 2011-12-14
US61/570,620 2011-12-14
US201261596869P 2012-02-09 2012-02-09
US61/596,869 2012-02-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014547503A Division JP6366507B2 (ja) 2011-12-14 2012-12-14 コラーゲン結合タンパク質による治療剤の送達

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020000376A Division JP2020073554A (ja) 2011-12-14 2020-01-06 コラーゲン結合タンパク質による治療剤の送達

Publications (3)

Publication Number Publication Date
JP2018104461A JP2018104461A (ja) 2018-07-05
JP2018104461A5 true JP2018104461A5 (enExample) 2018-09-27
JP6697019B2 JP6697019B2 (ja) 2020-05-20

Family

ID=48613370

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2014547503A Active JP6366507B2 (ja) 2011-12-14 2012-12-14 コラーゲン結合タンパク質による治療剤の送達
JP2018038513A Active JP6697019B2 (ja) 2011-12-14 2018-03-05 コラーゲン結合タンパク質による治療剤の送達
JP2020000376A Pending JP2020073554A (ja) 2011-12-14 2020-01-06 コラーゲン結合タンパク質による治療剤の送達
JP2021172953A Active JP7327765B2 (ja) 2011-12-14 2021-10-22 コラーゲン結合タンパク質による治療剤の送達
JP2023121669A Pending JP2023153154A (ja) 2011-12-14 2023-07-26 コラーゲン結合タンパク質による治療剤の送達

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014547503A Active JP6366507B2 (ja) 2011-12-14 2012-12-14 コラーゲン結合タンパク質による治療剤の送達

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2020000376A Pending JP2020073554A (ja) 2011-12-14 2020-01-06 コラーゲン結合タンパク質による治療剤の送達
JP2021172953A Active JP7327765B2 (ja) 2011-12-14 2021-10-22 コラーゲン結合タンパク質による治療剤の送達
JP2023121669A Pending JP2023153154A (ja) 2011-12-14 2023-07-26 コラーゲン結合タンパク質による治療剤の送達

Country Status (7)

Country Link
US (3) US9579273B2 (enExample)
EP (4) EP3391899B1 (enExample)
JP (5) JP6366507B2 (enExample)
CA (2) CA2859412C (enExample)
DK (2) DK2790717T3 (enExample)
ES (3) ES2695161T3 (enExample)
WO (1) WO2013090770A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2675174T3 (es) 2007-04-09 2018-07-09 The Board Of Trustees Of The University Of Arkansas Proteínas de fusión de un dominio de enlazamiento a colágeno y hormona paratiroidea
WO2013120060A1 (en) 2012-02-09 2013-08-15 The Board Of Trustees Of The University Of Arkansas Delivery of therapeutic agents by a collagen binding protein
EP3391899B1 (en) * 2011-12-14 2020-07-15 The Board of Trustees of the University of Arkansas Delivery of therapeutic agents by a collagen binding protein
WO2018148573A1 (en) 2017-02-10 2018-08-16 The Board Of Trustees Of The University Of Arkansas Collagen-binding agent compositions and methods of using the same
GB201706781D0 (en) 2017-04-28 2017-06-14 Univ Sheffield Parathyroid hormone fusion polypeptide
KR101964376B1 (ko) * 2017-09-29 2019-04-01 주식회사 나이벡 부갑상선호르몬(parathyroid hormone, PTH)에 골조직 선택성 펩타이드가 결합되어 있는 융합 펩타이드를 포함하는 약학 조성물 및 생체재료
JP7045166B2 (ja) * 2017-11-07 2022-03-31 株式会社ニッピ コラーゲン結合材、その製造方法、ドラッグデリバリーシステム、および担持体
EP3762429A4 (en) * 2018-03-09 2022-03-23 University of Pittsburgh - Of the Commonwealth System of Higher Education DELIVERY OF BIOLOGICAL AGENTS TO TISSUE
WO2021041954A2 (en) * 2019-08-28 2021-03-04 The Research Foundation For The State University Of New York Targeted delivery of tumor matrix modifying enzymes
JP7774276B2 (ja) * 2020-09-02 2025-11-21 コラジェン・ファーマ株式会社 ペプチドを含む組成物及びその用途
US12403179B2 (en) 2021-02-18 2025-09-02 The Board Of Trustees Of The University Of Arkansas Release of growth factors at wound healing stages
JP2025521751A (ja) * 2022-06-27 2025-07-10 サステイン ホールディングス,エルエルシー コラーゲンペプチドベースの医薬組成物及びその使用

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8516421D0 (en) 1985-06-28 1985-07-31 Biotechnology Interface Ltd Fibronectins
ATE209887T1 (de) 1993-04-02 2001-12-15 Anticancer Inc Verfahren zur verabreichung von förderlichen zusammensetzungen auf die haarfollikel
AU3819497A (en) 1996-07-31 1998-02-20 General Hospital Corporation, The Novel parathyroid hormone-related peptide analogs
US20100267012A1 (en) * 1997-11-04 2010-10-21 Bergeron Michel G Highly conserved genes and their use to generate probes and primers for detection of microorganisms
US6387663B1 (en) 1998-07-31 2002-05-14 University Of Southern California Targeting pharmaceutical agents to injured tissues
US7601685B2 (en) 1998-08-27 2009-10-13 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
EP1151116A1 (en) 1999-02-19 2001-11-07 Terumo Kabushiki Kaisha Collagen-binding physiologically active polypeptide
US20020102709A1 (en) 1999-02-19 2002-08-01 Tetsuya Ishikawa Collagen-binding physiologically active polypeptide
US6908994B1 (en) 1999-05-10 2005-06-21 The Texas A&M University System Collagen-binding proteins from enterococcal bacteria
US6756480B2 (en) * 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US20050124537A1 (en) 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
EP1314780A4 (en) 2000-08-15 2004-07-28 Terumo Corp Collagen-binding hybrid polypeptides
JP2002058485A (ja) * 2000-08-16 2002-02-26 Terumo Corp コラーゲン結合性を有する骨形成促進融合蛋白質
ES2301697T3 (es) 2001-12-18 2008-07-01 Eidgenossisch Technische Hochschule Zurich Matrices de proteina modificada con factor de crecimiento para ingenieria de tejidos.
WO2004011484A2 (en) 2002-07-25 2004-02-05 The General Hospital Corporation Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
AU2003203316B2 (en) 2003-02-13 2007-01-11 Synthes Gmbh Injectable bone-replacement mixture
US20040220094A1 (en) 2003-05-01 2004-11-04 Skinner Keith K. Inverse agonist and agonist peptides that stimulate/inhibit hair growth
WO2005041865A2 (en) 2003-10-21 2005-05-12 Igf Oncology, Llc Compounds and method for treating cancer
WO2005046798A1 (en) 2003-11-12 2005-05-26 Nps Allelix Corp. Treatment of bone loss utilizing full length parathyroid hormone
EP1557176A1 (en) 2004-01-26 2005-07-27 Ferring B.V. Treatment of bone metastases by means of PTH receptor agonists
US8030448B2 (en) * 2004-02-16 2011-10-04 Techno Network Shikoku Co., Ltd. Polypeptide having collagen-like structure
WO2005082941A1 (en) 2004-02-27 2005-09-09 The University Of Western Ontario Bone sialoprotein collagen-binding peptides
PL2348114T3 (pl) 2004-04-21 2019-08-30 Alexion Pharmaceuticals, Inc. Koniugaty do dostarczania do kości i sposób ich wykorzystania do nakierowywania białek na kość
CA2582552A1 (en) 2004-10-21 2006-05-04 Igf Oncology, Llc Toxins and radionuclides coupled to igf-1 receptor ligands for treatment of cancer
WO2006073711A2 (en) 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
US8802396B2 (en) * 2005-12-26 2014-08-12 Yantai Zhenghai Bio-Technology Co., Ltd. Activated collagen scaffold materials and their special fused active restoration factors
US8987200B2 (en) * 2006-11-16 2015-03-24 Kai Pharmaceuticals, Inc. Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders
EP1961765A1 (en) 2006-12-08 2008-08-27 Zealand Pharma A/S Truncated PTH peptides with a cyclic conformation
WO2008101406A1 (en) * 2007-02-14 2008-08-28 Yolare Dermaceuticals, Llc Modified mutant collagenase and it's use in fat melting and in scar reduction
WO2008123166A1 (en) * 2007-03-20 2008-10-16 Nsk-Warner K.K. Roller-type one-way clutch
ES2675174T3 (es) * 2007-04-09 2018-07-09 The Board Of Trustees Of The University Of Arkansas Proteínas de fusión de un dominio de enlazamiento a colágeno y hormona paratiroidea
US8486422B2 (en) * 2007-07-26 2013-07-16 Allergan, Inc. Methods of activating clostridial toxins
US20100159564A1 (en) * 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
JP5400336B2 (ja) 2008-08-04 2014-01-29 トヨタ紡織株式会社 表皮材の成形装置
US10545149B2 (en) 2008-10-06 2020-01-28 Morehouse School Of Medicine Detection of HIV-related proteins in urine
JP2010172247A (ja) 2009-01-29 2010-08-12 Kitasato Institute 積層型高密度培養人工組織の製造方法及び積層型高密度培養人工組織
US10046040B2 (en) * 2009-11-16 2018-08-14 University Of Maryland, Baltimore Multivalent live vector vaccine against Clostridium difficile-associated disease
JPWO2011142425A1 (ja) 2010-05-12 2013-07-22 国立大学法人 香川大学 上皮層含有組織の再生材および再生評価方法
ES2385239B1 (es) * 2010-09-30 2013-06-19 Proteos Biotech S.L.U. Uso de colagenasa g recombinante, colagenasa h recombinante y pz-peptidasa recombinante para el tratamiento de enfermedades que cursan con alteraciones del colágeno.
CN103562719B (zh) * 2011-03-16 2016-01-13 国立大学法人东北大学 生物体组织分析用探针及其使用方法
EP2708246B1 (en) * 2011-05-13 2017-11-01 School Juridical Person Kitasato Institute Growth factor anchoring type bone graft material, method for producing growth factor anchoring type bone graft material, kit for producing growth factor anchoring type bone graft material.
EP3391899B1 (en) * 2011-12-14 2020-07-15 The Board of Trustees of the University of Arkansas Delivery of therapeutic agents by a collagen binding protein
WO2013120060A1 (en) * 2012-02-09 2013-08-15 The Board Of Trustees Of The University Of Arkansas Delivery of therapeutic agents by a collagen binding protein
EP4276180B1 (en) * 2012-01-12 2026-04-22 Endo Biologics Limited Clostridium histolyticum enzyme
WO2013120030A1 (en) * 2012-02-08 2013-08-15 Shining Golden Yida Welding & Cutting Machinery Manufacture Ltd. Rotary vane air motor with improved vanes and other improvements
US9962428B2 (en) * 2012-12-21 2018-05-08 National University Corporation Nagoya University Composition having tissue-repairing activity, and use therefor
EP3048904A2 (en) * 2013-09-25 2016-08-03 Pronutria Biosciences, Inc. Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
US9539363B2 (en) * 2014-04-24 2017-01-10 Warsaw Orthopedic, Inc. Collagen matrix
US20180140742A1 (en) * 2014-10-16 2018-05-24 School Juridical Person Kitasato Institute Graft material for nerve regeneration, method for producing graft material for nerve regeneration, and kit for producing graft material for nerve regeneration
EP3112474A1 (en) * 2015-06-29 2017-01-04 Evonik Degussa GmbH Method of detecting avian necrotic enteritis
US10513696B2 (en) * 2016-05-24 2019-12-24 Hamzeh Alipour Lucilia sericata collagenase
RS64440B1 (sr) * 2016-09-29 2023-09-29 Ascendis Pharma Bone Diseases As Režim doziranja za pth jedinjenje sa kontrolisanim oslobađanjem
WO2018148573A1 (en) * 2017-02-10 2018-08-16 The Board Of Trustees Of The University Of Arkansas Collagen-binding agent compositions and methods of using the same
US20190248881A1 (en) * 2017-12-04 2019-08-15 Precithera, Inc. TGF-ß RECEPTOR FUSION PROTEINS AND OTHER TGF-ß ANTAGONISTS FOR REDUCING TGF-ß SIGNALING
EP3743081A4 (en) * 2018-01-23 2021-12-01 New York University SPECIFIC ANTIBODIES OF THE DELTA 1 CHAIN OF THE T-LYMPHOCYTE RECEPTOR
EP3762429A4 (en) * 2018-03-09 2022-03-23 University of Pittsburgh - Of the Commonwealth System of Higher Education DELIVERY OF BIOLOGICAL AGENTS TO TISSUE
ES3004565T3 (en) * 2018-08-14 2025-03-12 Ossifi Therapeutics Llc Pyrrolo - dipyridine compounds for the treatment of bone loss

Similar Documents

Publication Publication Date Title
JP2015513312A5 (enExample)
RU2012151205A (ru) Модифицированные связывающие белки, ингибирующие взаимодействие vegf-a рецептора
JP2014508510A5 (enExample)
JP7752152B2 (ja) 手術前、手術中または手術後に投与するためのglp-2類似体及びglp-2ペプチボディ
AU2019366366B2 (en) Therapeutic combinations of TDFRPs and additional agents and methods of use
Bruno et al. Angiogenic factors and ovarian follicle development
JP2009545313A5 (enExample)
JP2016510763A5 (enExample)
IL275936B2 (en) Activin receptor type iib variants and methods of using them
RU2018118025A (ru) Белки с двойной функцией и содержащая их фармацевтическая композиция
JP5002603B2 (ja) 新規なペプチド及びこれの用途
JPH06511233A (ja) 骨の形成を促進するための骨成長因子および骨吸収阻害剤
CN102170896A (zh) 糖依赖性胰岛素释放肽的截短类似物
US20070021342A1 (en) Wound Healing
JP2005053930A5 (enExample)
KR20130093692A (ko) 포도당 의존적인 인슐린 분비 자극성 폴리펩타이드의 유사체
RU2011110741A (ru) Основанные на notch3 человека гибридные белки в качестве ловушек-ингибиторов передачи сигнала notch3
JP2009515529A5 (enExample)
US5206354A (en) Dna sequence encoding active fragment of fibroblast growth factor, hbf-2
JP2023528207A5 (enExample)
JP2018104461A (ja) コラーゲン結合タンパク質による治療剤の送達
RU2018108421A (ru) Рекомбинантные белки и их применения в терапевтических целях
JP2020508984A5 (enExample)
CA2751636C (en) Analogues of neuropeptide y having at least one synthetic amino acid substitution
JP2025060836A5 (enExample)